BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$78.3M |
| 2 |
PG&E
PCG
|
+$68.5M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$58.9M |
| 4 |
Deere & Co
DE
|
+$47.4M |
| 5 |
iShares MSCI Japan ETF
EWJ
|
+$28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$1.43B |
| 2 |
Apple
AAPL
|
+$1.02B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$792M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$707M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$641M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 4.88% |
| 2 | Financials | 4.8% |
| 3 | Healthcare | 4.48% |
| 4 | Technology | 4.38% |
| 5 | Consumer Discretionary | 4.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
Escalade
ESCA
$294M
| $37.6K | ﹤0.01% |
3,058
+2,034
| +199% | +$27.1K |
|
3752
Duluth Holdings
DLTH
$151M
| $37.5K | ﹤0.01% |
2,100
+1,103
| +111% | +$20.4K |
|
3753
PDS Biotechnology
PDSB
$40.9M
| $37.5K | ﹤0.01% |
200
+109
| +120% | +$21.9K |
|
3754
Forte Biosciences
FBRX
$1.57B
| $37.4K | ﹤0.01% |
10
+8
| +400% | +$31.9K |
|
|
ICD
3755
DELISTED
Independence Contract Drilling, Inc.
ICD
| $37.4K | ﹤0.01% |
470
+338
| +256% | +$24.6K |
|
|
DCPH
3756
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $37.3K | ﹤0.01% |
+1,645
| New | +$32.2K |
|
3757
Gencor Industries
GENC
$235M
| $37.3K | ﹤0.01% |
2,251
+1,384
| +160% | +$24.2K |
|
|
JAX
3758
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $37K | ﹤0.01% |
3,817
+2,519
| +194% | +$26.2K |
|
3759
TFS Financial
TFSL
$4.83B
| $36.9K | ﹤0.01% |
2,473
-189
| -7% | -$2.91K |
|
3760
RPC Inc
RES
$1.36B
| $36.5K | ﹤0.01% |
1,429
-4,025
| -74% | -$96.9K |
|
3761
Simulations Plus
SLP
$371M
| $36.4K | ﹤0.01% |
2,260
+1,193
| +112% | +$19.6K |
|
|
AREX
3762
DELISTED
Approach Resources Inc.
AREX
| $36.3K | ﹤0.01% |
12,253
+8,054
| +192% | +$19.9K |
|
|
HOME
3763
DELISTED
At Home Group Inc.
HOME
| $36.3K | ﹤0.01% |
1,193
+569
| +91% | +$13.8K |
|
|
DLA
3764
DELISTED
Delta Apparel Inc.
DLA
| $36.2K | ﹤0.01% |
1,793
+1,148
| +178% | +$23.9K |
|
|
ITCI
3765
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $36.2K | ﹤0.01% |
+2,500
| New | +$38.6K |
|
|
LEAF
3766
DELISTED
Leaf Group Ltd.
LEAF
| $36.1K | ﹤0.01% |
3,642
+2,486
| +215% | +$19.5K |
|
|
ATHX
3767
DELISTED
Athersys, Inc. Common Stock
ATHX
| $36K | ﹤0.01% |
797
+462
| +138% | +$22.4K |
|
|
SCHW
3768
CALL
Charles Schwab
SCHW
$187B
| $36K | ﹤0.01% |
700
+650
| +1,300% | +$30.5K |
|
|
ITI
3769
DELISTED
Iteris, Inc.
ITI
| $35.9K | ﹤0.01% |
5,156
+2,855
| +124% | +$19.4K |
|
|
PETQ
3770
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $35.9K | ﹤0.01% |
1,643
+1,250
| +318% | +$28.8K |
|
3771
Build-A-Bear
BBW
$467M
| $35.8K | ﹤0.01% |
3,892
+2,739
| +238% | +$23.4K |
|
|
PMBC
3772
DELISTED
Pacific Mercantile Bancorp
PMBC
| $35.6K | ﹤0.01% |
4,071
+2,986
| +275% | +$27.5K |
|
|
GTHX
3773
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $35.5K | ﹤0.01% |
1,790
+1,343
| +300% | +$28.9K |
|
|
REIS
3774
DELISTED
Reis, Inc.
REIS
| $35.3K | ﹤0.01% |
1,710
+1,045
| +157% | +$20.2K |
|
|
KEG
3775
DELISTED
Key Energy Services, Inc. Common Stock
KEG
| $35.3K | ﹤0.01% |
2,992
+1,985
| +197% | +$21.9K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2017 Portfolio in Review
As of Q4 2017, BNP Paribas Financial Markets held 4,431 positions worth $56.4B, up 38% from $40.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
BNP Paribas Financial Markets deployed $12.4B of net new capital in Q4 2017, opening 182 new positions and adding to 2,292 existing holdings. Its largest new stake was VanEck Junior Gold Miners ETF: 1,804,222 shares worth $61.6M.
By sector, the portfolio is most concentrated in Communication Services at 4.9% of assets, down from 9.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Citigroup, an estimated $1.43B trimmed.
- BNP Paribas Financial Markets's largest Q4 2017 buy was VanEck Junior Gold Miners ETF: 1,804,222 shares worth $61.6M.
- BNP Paribas Financial Markets added most to iShares Core S&P 500 ETF in Q4 2017, an estimated $78.3M increase.
- BNP Paribas Financial Markets's biggest Q4 2017 reduction was Citigroup, cutting an estimated $1.43B.
- BNP Paribas Financial Markets fully exited CR Bard Inc. in Q4 2017, selling an estimated $113M.
- BNP Paribas Financial Markets's ten largest holdings make up 22% of its $56.4B portfolio in Q4 2017.
- BNP Paribas Financial Markets opened 182 new positions and closed 204 in Q4 2017.
- BNP Paribas Financial Markets's portfolio value rose 38% quarter-over-quarter to $56.4B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2017, filed 1 Feb 2018.